Stocks & Investing
Stocks and Investing
Stocks and Investing 
Mon, October 24, 2011
PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL), Up By 6.64% ($1.35) After BUYINS.NET SqueezeTrigger Report Released on Friday, Octobe
October 24, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Friday, October 21st 2011 at 11:15:00 PDT stating that PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) was expected to be Up After it crossed above its SqueezeTrigger Price of 20.32 on Friday, October 21st 2011. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=prxl&id=202820
From August 2009 to September 2011, an aggregate amount of 110766559 shares of PRXL have been shorted for a total dollar value of $2215331180. The PRXL SqueezeTrigger price of $20.32 is the volume weighted average price that all shorts are short in shares of PRXL. There is still approximately $104,483,329 of potential short covering in shares of PRXL.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .
PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) - PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications, and consulting services, as well as advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. It operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management and biostatistics, data management, clinical logistics, and clinical pharmacology, as well as related medical advisory, patient recruitment, and investigator site services. It manages various aspects of clinical trials, such as study and protocol design, case report form design, site and investigator recruitment, patient enrollment, study monitoring and data collection, data analysis, report writing, and medical services. This segment provides services in therapeutic areas comprising cardiology, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics, psychiatry, and transplantation. The PCMS segment offers technical advice in areas, such as drug development, regulatory affairs, and biopharmaceutical process and management consulting. It also provides market and product development, and targeted communications services in support of product launch. In addition, its consultants identify alternatives and propose solutions to address clients product development, registration, and commercialization issues, as well as offers health policy consulting, and reimbursement and market access services. The Perceptive segment provides information technology solutions comprising medical imaging and systems integration services; RTSM, CTMS, and EDC products; Web-based portals; and patient diary applications. The company was founded in 1983 and is headquartered in Waltham, Massachusetts.
The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
GATS -- tracks and quantifies known trading strategies.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net